You have to appreciate the loser that didn’t get picked up by Biohaven because his numbers suck and he can’t sell. Enjoy being last in country ML and leave her alone.
-
Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page
Biohaven Pharmaceuticals
- Thread starter anonymous
- Start date
-
- Tags
- None
You guys need to remember Allergan is not Allergan anymore. Allergan is Abby which means you guys are big Pharma! Stumbling bumbling and don’t have any say in anything you do. Or who you see or what happens next. It’s going to implode get out!
Have you seen our speaker list? Or the national thought leaders that have conducted our studies? Dodick, Blumenfeld and Lipton !!! They’re all on board the Biohaven train. Better get on board or you’re going to get run over!
The O.IG. Is watching this very closely, as they are with The promotion of all other marginal clinical improvements in therapy and promotions around said compounds. Tread lightly.
Sorry buddy, but they all have published studies on Ubrogepant. Hate to be the one to burst your bubble, but these big dogs support it all. Not an isolated benefit to Biohaven. Do some research. 
Yes, they are the same ones who speak for and did studies for Amgen, Lilly, Teva, Alder, Allergan and all the device companies. Yippee. ICER guidelines not favorable, for acute, just use generic Zomig ZMT or Maxalt MLT.
Good luck Biohaven. It better be good or you are out. Allergan has presence already and if you are the same it’s a no go. Late to the party .. tough to catch up. 5 reps quit in our area and have moved on.. writing on the wall
Customers favor the Ivy League Amgen country club pedigree and their first to market, superior drug. They won't sink to using a triptan with lipstick on it from a chop shop, penny stock wannabe company. There will be limited pen to pad and profitability will never be reached. The Wharton noodlers at Amg have run every model and the result is the same, infinite disaster.
I’d call being a month behind Allergan fashionably late to the party. We will be ok.
so the same docs that have whored themselves out to every other migraine company?
congratulations!
Yep so now it's an equal playing field; may the best rep win!!
The “best rep” works for UHC and will block this 20 ways to Sunday.
Your company is a train wreck. Spin it however you want. Last into market.. nothing special.. good luck..
I can see how you would be bitter , the pay here is pretty darn good. Certainly a lot better than unemployment
best rep..tallest midget...it's all the same